<DOC>
	<DOCNO>NCT01575054</DOCNO>
	<brief_summary>This study evaluate safety efficacy BOTOX® treatment adult post-stroke low limb spasticity .</brief_summary>
	<brief_title>BOTOX® Treatment Adult Patients With Post-Stroke Lower Limb Spasticity</brief_title>
	<detailed_description />
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Diagnosis poststroke low limb spasticity least 3 month Minimum body weight 50 kg Never treat botulinum toxin serotype reason , previously treat botulinum toxin serotype , previously treat spasticity affect low limb , must administer 20 week Day 1 , previously treat indication must administer ≥12 week prior Day 1 Spasticity opposite leg require treatment Casting study limb within 6 month plan cast first 12 week study Treatment modality study limb include ultrasound , electrical nerve stimulation , electrical stimulation , acupuncture within 1 month Day 1 treatment plan study Not able perform 10 meter walk test independently without assistive device Diagnosis myasthenia gravis , EatonLambert syndrome , amyotrophic lateral sclerosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>